Mesenteric Sparing Surgery in Laparoscopic Colorectal Resection for Endometriosis (IRE-1)

September 28, 2021 updated by: Antonio Simone Laganà, Università degli Studi dell'Insubria

Analysis of Surgical Outcomes in Women Undergoing Mesenteric Vascular and Nerve Sparing Surgery in Laparoscopic Segmental Colorectal Resection for Deep Infiltrating Endometriosis

Colorectal resection is a standard surgical treatment of bowel deep infiltrating endometriosis (DIE). Nevertheless, concerns about different bowel functional outcomes related to radical surgery versus conservative surgery as shaving technique is a topic leading to much debate. Different surgical approach are used to perform colorectal resection and there is not a standardized technique. For the same concerns, studies have addressed the mesenteric vascular and nerve preservation both in oncological and benign intestinal disease with improved functional outcome. Therefore, the aim of this prospective study is to analyze feasibility and safety of mesenteric vascular and nerve Sparing Surgery in laparoscopic segmental colorectal resection for DIE with short and long term follow up. Women with DIE ,that underwent laparoscopic segmental colorectal resection, will undergo resection performed with inferior mesenteric artery and branching arteries preservation by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved. Personal history, clinical data, surgical data, short and long term surgical complications and long term outcomes will be recorded. Symptoms and bowel function will be evaluated before and after surgery.

Study Overview

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 45 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women with deep infiltrating endometriosis underwent laparoscopic surgery treatment with segmental intestinal resection.

Description

Inclusion Criteria:

  • Patients referred for bowel endometriosis requiring colorectal resection

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Women underwent colorectal resection for endometriosis
Women referred for colorectal resection for deep infiltrating endometriosis that underwent laparoscopic segmental colorectal resection performed with mesenteric vascular and nerve sparing surgery.
Laparoscopic segmental colorectal resection performed by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in endometriosis related dysmenorrhea evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dysmenorrhea at 60 days after surgery and at 1 year after surgery
Dysmenorrhea in 0 - 10 range according to the Numeric Rating Scale for Pain
Change from baseline dysmenorrhea at 60 days after surgery and at 1 year after surgery
Change in endometriosis related dyschezia evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dyschezia at 60 days after surgery and at 1 year after surgery
Dyschezia in 0 - 10 range according to the Numeric Rating Scale for Pain
Change from baseline dyschezia at 60 days after surgery and at 1 year after surgery
Change in endometriosis related dyspareunia evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dyspareunia at 60 days after surgery and at 1 year after surgery
Dyspareunia in 0 - 10 range according to the Numeric Rating Scale for Pain.
Change from baseline dyspareunia at 60 days after surgery and at 1 year after surgery
Change in endometriosis related dysuria evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dysuria at 60 days after surgery and at 1 year after surgery
Dysuria in 0 - 10 range according to the Numeric Rating Scale for Pain.
Change from baseline dysuria at 60 days after surgery and at 1 year after surgery
Change in endometriosis related pelvic chronic pain evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline pelvic chronic pain at 60 days after surgery and at 1 year after surgery
Pelvic chronic pain in 0 - 10 range according to the Numeric Rating Scale for Pain.
Change from baseline pelvic chronic pain at 60 days after surgery and at 1 year after surgery
Change in bowel symptoms evaluated by Constipation Assessment Scale
Time Frame: Change from baseline bowel symptoms at 60 days after surgery and at 2 year after surgery
Bowel symptoms in 0 - 16 range according to the Constipation Assessment Scale. Constipation Assessment Scale includes eight items, each of which is self-rated by the patient as 'no problem' (score of 0), 'some problem' (score of 1), or 'severe problem' (score of 2). The item ratings are then summed, so the overall score may range from 0 (no constipation) to 16 (worst possible constipation).
Change from baseline bowel symptoms at 60 days after surgery and at 2 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endometriosis characteristics
Time Frame: intraoperative
rAFS classification
intraoperative
Complication rate
Time Frame: Within 6 months after surgery
Number of surgical complications (Clavien-Dindo Classification)
Within 6 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Antonio Simone Laganà, M.D., Uninsubria
  • Principal Investigator: Paola Pomini, M.D., Universita di Verona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

May 1, 2022

Primary Completion (ANTICIPATED)

May 1, 2023

Study Completion (ANTICIPATED)

May 1, 2024

Study Registration Dates

First Submitted

May 30, 2018

First Submitted That Met QC Criteria

June 11, 2018

First Posted (ACTUAL)

June 21, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 30, 2021

Last Update Submitted That Met QC Criteria

September 28, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

Clinical Trials on Mesenteric vascular and nerve sparing surgery in laparoscopic segmental colorectal resection

Subscribe